China Universal Asset Management »

Cullinan Oncology shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $153k 9.0k 17.01
2023-12-31 $50k 5.0k 10.09
2023-09-30 $10k 1.1k 9.13
2023-06-30 $6.0k 516 11.63
2023-03-31 $5.0k 533 9.38
2022-12-31 $5.0k 465 10.75
2022-09-30 $5.0k 427 11.71

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Cullinan Oncology

Blue Owl Capital Holdings
Franklin Resources
BVF
Vanguard Group
Braidwell
American International
Nextech Invest
Citadel Advisors
Dimensional Fund Advisors
Tang Capital Management
Rubric Capital Management
Deutsche Bank Aktiengesellschaft
OrbiMed Advisors
Charles Schwab Investment Management
Millennium Management

View all funds holding Cullinan Oncology